Younger age (<18 months) and MYCN amplification were also associated with lower frequency of persistent BM tumor, but with borderline significance.
← all excerpts
Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma.
1
—
—